Page last updated: 2024-10-19

niacin and Age-Related Memory Disorders

niacin has been researched along with Age-Related Memory Disorders in 5 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
" The evaluation of the side effects present shortly after dosing in the rotarod test has revealed neurotoxicity of Nic-BZA with experimentally determined TD50 value of 188."5.43Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice. ( Paruszewski, R; Świąder, K; Świąder, MJ; Turski, WA; Łuszczki, JJ, 2016)
" The evaluation of the side effects present shortly after dosing in the rotarod test has revealed neurotoxicity of Nic-BZA with experimentally determined TD50 value of 188."1.43Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice. ( Paruszewski, R; Świąder, K; Świąder, MJ; Turski, WA; Łuszczki, JJ, 2016)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Wong-Guerra, M2
Montano-Peguero, Y2
Ramírez-Sánchez, J2
Jiménez-Martin, J2
Fonseca-Fonseca, LA2
Hernández-Enseñat, D1
Nonose, Y1
Valdés, O1
Mondelo-Rodriguez, A2
Ortiz-Miranda, Y1
Bergado, G1
Carmenate, T1
Soto Del Valle, RM1
Pardo-Andreu, G1
Outeiro, TF1
Padrón-Yaquis, AS2
Martimbianco de Assis, A1
O Souza, D1
Nuñez-Figueredo, Y2
Rocha, JB1
D Avila, F1
de Assis, AM1
Souza, DO1
Pardo-Andreu, GL1
Del Valle, RM1
Lopez, GA1
Martínez, OV1
García, NM1
Świąder, MJ1
Łuszczki, JJ1
Paruszewski, R1
Świąder, K1
Turski, WA1
Dormehl, IC1
Jordaan, B1
Oliver, DW1
Croft, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Brain Changes in Pediatric Obstructive Sleep Apnea[NCT05368077]70 participants (Anticipated)Interventional2022-05-14Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for niacin and Age-Related Memory Disorders

ArticleYear
SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs.
    Clinical nuclear medicine, 1999, Volume: 24, Issue:1

    Topics: Administration, Oral; Aged; Aging; Brain; Cerebellum; Cerebrovascular Circulation; Cognition; Cross-

1999

Other Studies

4 other studies available for niacin and Age-Related Memory Disorders

ArticleYear
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats.
    Neurotoxicology, 2021, Volume: 87

    Topics: Aluminum Chloride; Animals; Benzodiazepines; Hippocampus; Male; Maze Learning; Memory; Memory Disord

2021
JM-20 protects memory acquisition and consolidation on scopolamine model of cognitive impairment.
    Neurological research, 2019, Volume: 41, Issue:5

    Topics: Acetylcholinesterase; Animals; Antioxidants; Benzodiazepines; Brain; Cholinesterase Inhibitors; Cogn

2019
Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:2

    Topics: Animals; Anticonvulsants; Benzyl Compounds; Disease Models, Animal; Male; Memory Disorders; Memory,

2016
Brain bonus with niacin?
    Harvard heart letter : from Harvard Medical School, 2004, Volume: 15, Issue:2

    Topics: Alzheimer Disease; Humans; Hypolipidemic Agents; Memory Disorders; Niacin; Vasodilator Agents

2004